secukinumab (cosentyx) Report issue

Biologics mAb Approved FDA First in Class
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB
Back

Drug Pricing Summary

AUS PBS

$542.4774 - $547.7262

VA Big4

$1832.0750 - $3747.7600

VA FSS

$2739.1700 - $5478.3400

NADAC

$2872.9471

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
secukinumab 150 mg / 1 mL (1 mL INJECTION) $542.4774 AUS PBS generic
  • Cosentyx (2)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    secukinumab 150 mg / 1 mL (1 mL INJECTION) $547.7262 AUS PBS generic
  • Cosentyx (1)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    secukinumab 150 mg / 1 mL (1 mL INJECTION) $1832.0750 VA Big4
  • COSENTYX (2)
    		•  Novartis Pharmaceuticals Corporation
    secukinumab 150 mg / 1 mL (1 mL INJECTION) $1844.4000 VA Big4
  • COSENTYX (2)
    		•  Novartis Pharmaceuticals Corporation
    secukinumab 150 mg / 1 mL (1 mL INJECTION) $2739.1700 VA FSS
  • COSENTYX (2)
    		•  Novartis Pharmaceuticals Corporation
  • COSENTYX (2)
    		•  Novartis Pharmaceuticals Corporation
    secukinumab 150 mg / 1 mL (1 mL INJECTION) $2872.9471 NADAC brand
  • COSENTYX (1)
    		•  Novartis Pharmaceuticals Corporation
    secukinumab 150 mg / 1 mL (1 mL INJECTION) $3746.0200 VA Big4
  • COSENTYX (1)
    		•  Novartis Pharmaceuticals Corporation
    secukinumab 150 mg / 1 mL (1 mL INJECTION) $3747.7600 VA Big4
  • COSENTYX (1)
    		•  Novartis Pharmaceuticals Corporation
    secukinumab 150 mg / 1 mL (1 mL INJECTION) $5478.3400 VA FSS
  • COSENTYX (1)
    		•  Novartis Pharmaceuticals Corporation
  • COSENTYX (1)
    		•  Novartis Pharmaceuticals Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue